Researchers

Results 21-40 of 335
Issue DateTitleAuthor(s)TypeМp-cat.
2025Editorial on Special Issue: “Novel Therapeutic Strategies for Glioblastoma”Podolski-Renić, Ana  ; Dinić, Jelena  ; Pešić, Milica  Contribution to periodical
21aM21a
2025Personalized Genomic Analysis for Clinical Insights in Non-Small Cell Lung CancerDragoj, Miodrag  ; Jovanović Stojanov, Sofija  ; Podolski-Renić, Ana  ; Dinić, Jelena  ; Stepanović, Ana  ; Lupšić, Ema  ; Pajović, Milica  ; Petrović Rodić, Dušica; Glumac, Sofija; Marić, Dragana;
Ercegovac, Maja; Pešić, Milica  ;
Conference Paper
Mp. category will be shown later
2025Novel pyrimidine-artesunate hybrids overcome multidrug-resistance in non-small cell lung carcinoma through collateral sensitivityKoračak, Ljiljana; Ajdačić, Vladimir  ; Selaković, Milica  ; Pajović, Milica  ; Novaković, Miroslav  ; Lupšić, Ema  ; Podolski-Renić, Ana  ; Zlatović, Mario  ; Pešić, Milica  ; Opsenica, Igor M.  Article
21aM21a
2025Associating Patient Responses with Drug Sensitivity in Non-Small Cell Lung Carcinoma Using an Immunoassay on Patient-Derived Cell CulturesPodolski-Renić, Ana  ; Jovanović Stojanov, Sofija  ; Marić, Dragana  ; Dinić, Jelena  ; Dragoj, Miodrag  ; Stepanović, Ana  ; Lupšić, Ema  ; Pajović, Milica  ; Glumac, Sofija; Ercegovac, Maja;
Pešić, Milica  ;
Article
22M22
2025Two novel pyrimidine-artesunate hybrids overcome multidrug-resistance in non-small cell lung carcinoma through collateral sensitivityPajović, Milica  ; Podolski-Renić, Ana  ; Lupšić, Ema  ; Koračak, Ljiljana; Ajdačić, Vladimir; Selaković, Milica; Novaković, Miroslav; Opsenica, Igor M.; Pešić, Milica  Conference Paper
Mp. category will be shown later
2025Development of a Clinically Relevant Temozolomide-Resistant Human Glioblastoma A-172 Cell LinePajović, Milica  ; Dinić, Jelena  ; Lupšić, Ema  ; Jovanović Stojanov, Sofija  ; Grozdanić, Marija  ; Pešić, Milica  ; Podolski-Renić, Ana  ; Dragoj, Miodrag  Conference Paper
Mp. category will be shown later
2025The impact of a protein phosphatase 2A inhibitor on glioblastoma and neurodegenerationChigriai, Margarita; Pešić, Vesna  ; Stanojlović, Miloš  ; Lupšić, Ema  ; Grozdanić, Marija  ; Podolski-Renić, Ana  ; Pešić, Milica  Conference Paper
Mp. category will be shown later
2025A simple alginate-based 3D in vitro model for preclinical anticancer drug evaluationPetrović, Jelena  ; Banićević, Ivana  ; Bojić, Luka  ; Milivojević, Milena  ; Dragoj, Miodrag  ; Jovanović Stojanov, Sofija  ; Pešić, Milica  ; Janković, Radmila  ; Obradović, Bojana  ; Stojkovska, Jasmina  Conference Paper
Mp. category will be shown later
2025Sclareol-based natural nanoparticles with adamantane moieties exert anticancer effects against non-small cell lung carcinoma cellsStojković, Pavle  ; Lupšić, Ema  ; Terzić-Jovanović, Nataša  ; Stepanović, Ana  ; Nedialkov, Paraskev; Podolski-Renić, Ana M.  ; Pešić, Milica  ; Opsenica, Igor M.  Article
21aM21a
2024Synthesis and anticancer activity of novel sclareol derivativesAjdačić, Vladimir  ; Stojković, Pavle; Nikolić, Andrea; Andrijević, Ana  ; Lupšić, Ema  ; Stepanović, Ana  ; Podolski-Renić, Ana  ; Terzić-Jovanović, Nataša; Pešić, Milica  ; Opsenica, Igor M.  Conference Paper
Mp. category will be shown later
2024Drug screening approaches for small-molecule compounds in cancer-targeted therapyZhao, Yelin; Yuan, Chenyu; Shi, Yuchen; Liu, Xiaohong; Luo, Liaoxin; Zhang, Li; Pesic, Milica S  ; Yao, Hongjuan; Li, LiangReviews
21M21
2024Functional Diagnostics in Personalized Therapy for Non-Small Cell Lung CarcinomaPodolski-Renić, Ana  ; Dinić, Jelena  ; Dragoj, Miodrag  ; Jovanović Stojanov, Sofija  ; Stepanović, Ana  ; Lupšić, Ema  ; Pajović, Milica  ; Glumac, Sofija; Marić, Dragana  ; Ercegovac, Maja;
Pešić, Milica  ;
Conference Paper
Mp. category will be shown later
2024Hybrid Compounds of Sclareol and Doxorubicin, their Synthesis and ApplicationPešić, Milica  ; Opsenica, Igor; Stepanović, Ana  ; Terzić-Jovanović, NatašaPatent
Mp. category will be shown later
2024Multidrug-Resistant Profiles in Non-Small Cell Lung Carcinoma Patient-Derived Cells: Implications for Personalized Approaches with Tyrosine Kinase InhibitorsDinić, Jelena  ; Dragoj, Miodrag  ; Jovanović Stojanov, Sofija  ; Stepanović, Ana  ; Lupšić, Ema  ; Pajović, Milica  ; Mohr, Thomas; Glumac, Sofija; Marić, Dragana  ; Ercegovac, Maja;
Podolski-Renić, Ana  ; Pešić, Milica  ;
Article
21M21
2024Synthesis of Artesunate-Pyrimidine Hybrids and Evaluation of Their Activity Against Multidrug-Resistant Cancer CellsKoračak, Ljiljana; Selaković, Milica  ; Lupšić, Ema  ; Podolski-Renić, Ana  ; Selaković, Života  ; Novaković, Miroslav  ; Pešić, Milica  ; Opsenica, Igor M.  Conference Paper
Mp. category will be shown later
2024Advancements in Personalized Therapy for Non-Small Cell Lung Carcinoma: The Role of Functional DiagnosticsDinić, Jelena  ; Dragoj, Miodrag  ; Jovanović Stojanov, Sofija  ; Stepanović, Ana  ; Lupšić, Ema  ; Pajović, Milica  ; Glumac, Sofija; Marić, Dragana  ; Ercegovac, Maja; Podolski-Renić, Ana  ;
Pešić, Milica  ;
Conference Paper
Mp. category will be shown later
2024Editorial: Natural products and nanoparticles in cancer treatment: is there a light at the end of the tunnel?Pesic, Milica  ; Chahardehi, Amir Modarresi; Echeverria, Javier; Talib, Wamidh HContribution to periodical
21aM21a
2024Development of a Biomimetic Platform for 3D Cancer Cell CulturesObradović, Bojana  ; Banićević, Ivana  ; Petrović, Jelena  ; Milivojević, Milena  ; Janković, Radmila  ; Dragoj, Miodrag  ; Pešić, Milica  ; Stojkovska, Jasmina  Conference Paper
Mp. category will be shown later
2024Novel hybrid compounds of sclareol and doxorubicin as potential anticancer nanotherapy for glioblastomaStepanović, Ana  ; Terzić Jovanović, Nataša  ; Korać, Aleksandra  ; Zlatović, Mario  ; Nikolić, Igor  ; Opsenica, Igor  ; Pešić, Milica  Article
21a+M21a+
2024Plant-Based Products Originating from Serbia That Affect P-glycoprotein ActivityDinić, Jelena  ; Podolski-Renić, Ana  ; Novaković, Miroslav  ; Li, Liang; Opsenica, Igor  ; Pešić, Milica  Article
21M21